GB1200940A - A method for solubilising enduracidin and aqueous solutions thereof - Google Patents
A method for solubilising enduracidin and aqueous solutions thereofInfo
- Publication number
- GB1200940A GB1200940A GB5244467A GB5244467A GB1200940A GB 1200940 A GB1200940 A GB 1200940A GB 5244467 A GB5244467 A GB 5244467A GB 5244467 A GB5244467 A GB 5244467A GB 1200940 A GB1200940 A GB 1200940A
- Authority
- GB
- United Kingdom
- Prior art keywords
- glycerol
- enduracidin
- solubilising
- polyoxyethylene
- nov
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
Abstract
1,200,940. Enduracidin preparations. TAKEDA YAKUHIN KOGYO K.K. 17 Nov., 1967 [19 Nov., 1966], No. 52444/67. Heading A5B. Aqueous enduracidin preparations having a pH between 3.5 and 8.0 comprise the antibiotic and, as solubilising agent, one or more of: a) a water-soluble non-ionic surfactant having a polyoxyethylene or polyoxypropylene chain in its molecule, b) a glycerol acetate and, c) glycerol α,α'-diethyl ether. A, C 5 or C 6 polyhydric alcohol, e.g. inositol or a hexitol or pentitol, may also be included. Specified solubilising agents are polyoxyethylene-sorbitan monooleate, -castor oil andhydrogenated castor oil; glycerol mono- and di-acetate, glycerol monostearate and glycerol α,α'-diethyl ether. Conventional excipients including preservatives and local anaesthetics may be present.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP7626966 | 1966-11-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1200940A true GB1200940A (en) | 1970-08-05 |
Family
ID=13600501
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB5244467A Expired GB1200940A (en) | 1966-11-19 | 1967-11-17 | A method for solubilising enduracidin and aqueous solutions thereof |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB1200940A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1063885A1 (en) * | 1998-03-24 | 2001-01-03 | Alonzo H. Jones | Xylitol compositions for treating upper respiratory conditions |
-
1967
- 1967-11-17 GB GB5244467A patent/GB1200940A/en not_active Expired
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1063885A1 (en) * | 1998-03-24 | 2001-01-03 | Alonzo H. Jones | Xylitol compositions for treating upper respiratory conditions |
EP1063885A4 (en) * | 1998-03-24 | 2002-09-18 | Alonzo H Jones | Xylitol compositions for treating upper respiratory conditions |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO872127L (en) | AEROUS STEROID PREPARATIONS FOR ADMINISTRATION THROUGH NESEN | |
ES8607721A1 (en) | Solubilization of ivermectin in water. | |
GB1518683A (en) | Pharmaceutical compositions | |
ES460743A1 (en) | Preserving liquid antacid medicinal formulations | |
GB1423244A (en) | Dilution agent | |
GB1200940A (en) | A method for solubilising enduracidin and aqueous solutions thereof | |
GB1328591A (en) | Paracetamol-containing medicines | |
KR910700002A (en) | New concentrated aqueous emulsion, method for its preparation and use as pesticide | |
GB1098151A (en) | Membrane penetrant compositions comprising dialkyl sulfoxides | |
GB1255007A (en) | Manufacturing method for ginseng cigarettes or the like | |
GB1174031A (en) | Peroral Contrast Medium for use in Radiological Examination of the Digestive Tract | |
FR2379284A1 (en) | NEW CHLORHEXIDINE-BASED MEDICINAL PRODUCT AND METHOD OF PREPARATION | |
GB1241832A (en) | Cosmetic preparations | |
GB1359044A (en) | Quinoline derivatives | |
GB1213154A (en) | A process for the solubilization of papaveroline and/or papaveroline tetrabenzoylate | |
GB1177511A (en) | Hair Treatment Lotion. | |
GB780886A (en) | Oral vitamin c preparations | |
RU94032143A (en) | Composition containing the preparation of coagulation factor viii, method of its preparing and the use of surface-active substance as stabilizing agent | |
GB1181527A (en) | Composition and Method for Treating Mastitis with Therapeutic Agents. | |
GB1353834A (en) | Benzenesulphonamides | |
Scherr | The therapeutic effect of cortisone, somatotrophic hormone, and hesperedin methyl chalcone in suppressing experimental moniliasis in mice | |
GB1217181A (en) | PROCESS OF SOLUBILISING 3alpha-HYDROXY-PREGNANE-11,20-DIONE | |
IE37718B1 (en) | Pharmaceutical compositions | |
GB1315275A (en) | Insecticide | |
Grebenshchikov et al. | Solid solutions in the system Ca sub 2 SiO sub 4- Sr sub 2 GeO sub 4 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PS | Patent sealed | ||
PLNP | Patent lapsed through nonpayment of renewal fees |